🌟 What an energizing few days at DCAT 2026 in New York!
We thoroughly enjoyed meeting so many of you; partners, innovators, and industry leaders from across the global pharma and biotech ecosystem. The conversations were insightful, the energy was high, and the connections made were genuinely valuable.
We were especially excited to share our latest commercial manufacturing approaches for peptides, oligonucleotides, and small molecules including our significant commercial capacity and supply capabilities as well as our extensive portfolio of DMFs. From robust scale-up strategies and high-purity processes to flexible capacity and regulatory-aligned quality systems, it was great to discuss how Sinopep is supporting complex API programs end-to-end from development through commercial supply.
A heartfelt thank you to everyone who visited our team, joined our discussions, or simply stopped by to say hello. Your interest and thoughtful questions made the event even more rewarding.
